Sanjay Murthy profile picture

Contact Information

Sanjay Murthy, MD, FRCPC
(613)737-8899 ext 73542
smurthy@toh.ca

ORCID logo https://orcid.org/0000-0002-0128-7897

Sanjay Murthy

Scientist, Inflammation & Chronic Disease
Ottawa Hospital Research Institute

Research Interests

Use of population-level health administrative data to evaluate impact and costs of current paradigms of care as it relates to inflammatory bowel diseases (IBD) and colorectal cancer prevention

Development of predictive tools for use in clinical practice and with studies that use health administrative data

Quality of care in IBD and colonoscopy

 

Brief Biography

Appointments:

Assistant Professor of Medicine and Clinician Investigator, Division of Gastroenterology

Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

Member of the Ottawa Hospital IBD Centre

Director, Home Parenteral Nutrition Program, The Ottawa Hospital

Cross-appointed at  Institute for Clinical Evaluative Sciences

Cross-appointed at School of Epidemiology, Public Health, and Preventive Medicine.


Training:

M.Sc., Clinical Epidemiology and Health Care Research, Institute of Health Policy, Management and Evaluation, University of Toronto

Advanced Clinical and Research Fellowship in Inflammatory Bowel Diseases, Mount Sinai Hospital, Toronto, Canada

Advanced Clinical Fellowship in Parenteral Nutrition, University of Toronto

Clinical and Research Fellowship in Endoscopic Imaging, Johannes Gutenberg University of Mainz, Mainz, Germany

Royal College Residency in Gastroenterology, University of Toronto

Royal College Residency in General Internal Medicine, University of Manitoba

Doctorate in Medicine (M.D.), University of Ottawa

B.Sc Honours, Biochemistry, University of Ottawa

Selected Publications

Murthy SK, Greenberg GR, Nguyen GC, et al. Extent of Early Clinical Response to infliximab Predicts Long-Term Treatment Success in Active Ulcerative Colitis. Inflamm Bowel Dis 2015 Sep;21(9):2090-6

Murthy SK, Nguyen GC. Increased Risk of Venous Thromboembolic Events With Corticosteroid Versus Biologic Therapy for Inflammatory Bowel Disease (Letter to Editor). Clin Gastroenterol Hepatol 2016 Jan;14(1):166-7

Murthy SK, Kiesslich R. Evolving Endoscopic Strategies for Neoplasia Detection and Treatment in Inflammatory Bowel Disease (Review). Gastrointest Endosc 2013 Mar;77(3):351-9.

Murthy SK, Steinhart AH, Tinmouth J, Daneman N, Austin PC and Nguyen GC. “Impact of Clostridium Difficile Colitis on Five-Year Health Outcomes of Ulcerative Colitis Patients. Aliment Pharmacol Ther 2012 Dec;36(11-12):1032-9.

Murthy SK, Steinhart AH, Tinmouth J, Austin PC and Nguyen GC. “Impact of gastroenterologist care on health outcomes of hospitalised ulcerative colitis patients.” Gut 2012 Oct;61(10):1410-6.

Murthy S, Goetz M, Hoffman A, Kiesslich R. “Novel Colonoscopic Imaging.” Clin Gastroenterol Hepatol 2012 Sep;10(9):984-7.

Murthy SK, Nguyen GC. “Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review.” Am J Gastroenterol 2011; 106(4):713-8.

Murthy SK, Heathcote EJ, Nguyen GC. “Impact of Cirrhosis and Liver Transplant on Maternal Health during Labour and Delivery.” Clin Gastroenterol Hepatol 2009; 7(12):1367-72.

Murthy S, Keyvani L, Leeson S, Targownik LE. “Intravenous versus high-dose oral proton pump inhibitor therapy after endoscopic hemostasis of high-risk lesions in patients with acute non-variceal upper gastrointestinal bleeding.” Dig Dis Sci 2007;52(7):1685-90.

Murthy SK, Kauldher S, Targownik LE. “Physicians’ approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug (NSAID) users.” Aliment Pharmacol Ther 2006 May 1;23(9):1365-72.


Diseases, conditions and populations of interest





Research and clinical approaches